Back to results
US 2004/0081619 A1Published application
Method of prophylaxis against large myocardial infarctions
OwnerLeonard Bellinventor
Life of this patent
Estimating the term…
Abstract
Methods of determining the effectiveness of anti-inflammatory compounds in reducing incidence of myocardial infarction are described. Methods of prophylaxis against myocardial infarctions which exhibit CK-MB levels greater than about 50 nano-grams/ml in a subject are also provided.
Claims13
The method of determining effectiveness of an anti-inflammatory compound in reducing incidence of myocardial infarction comprising:
- administering the compound to a subject group comprising at least one patient undergoing a procedure involving cardiopulmonary bypass;
- and
- comparing incidence of infarctions in the subject group to incidence of infarctions in a control sample of patients when the peak level of CK-MB in the blood is greater than 50 nano-grams/ml in both groups;
- wherein a decrease in the incidence of infarctions in the subject group indicates effectiveness of the compound.
1 more element
Dependencies are inferred from the claim text.